Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

Ozempic, Wegovy could reverse severe liver disease, study suggests

by
May 6, 2025
in Health Care
0
Ozempic, Wegovy could reverse severe liver disease, study suggests

Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study.

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known by brand names Ozempic and Wegovy, has the ability to counter metabolic dysfunction-associated steatohepatitis, or MASH, liver disease and some of its risk factors.

MASH is characterized by inflammation and scarring caused by fat buildup in the liver. It affects roughly 20 percent of adults in the U.S. and is closely associated with risk factors like Type 2 diabetes and high blood pressure, according to the Cleveland Clinic.

Researchers administered weekly injections — either a placebo or semaglutide — to 800 patients across 37 countries between 2021 and 2023.

More than half of participants had Type 2 diabetes, and 75 percent were obese.

After nearly 17 months of injections, 62.9 percent of semaglutide patients had less inflammation and fat accumulation in their livers; 34 percent of placebo patients saw the same results.

It also reduced liver scarring in 37 percent of patients, compared to the placebo’s 23 percent.

The study’s semaglutide subjects also saw 10.5 percent weight loss, as well as improvements in liver enzymes and liver fibrosis measurements.

Lead author Dr. Arun Sanyal said the study could offer a “promising new approach for millions of patients.”

“If approved, this could offer an additional therapeutic option for patients with MASH and fibrosis,” Sanyal said. “This is crucial, given the strong link between MASH and cardiovascular, metabolic, and renal conditions, where semaglutide has already shown established health benefits.”

Sanyal’s team plans to continue the research by studying 1,200 participants from 37 countries for up to five years to look into long-term liver issues.

Previous Post

Fewer than half of Americans trust FDA, CDC to do their job

Next Post

How halt in funding hurts efforts to ensure safety of patients in medical research

Next Post
How halt in funding hurts efforts to ensure safety of patients in medical research

How halt in funding hurts efforts to ensure safety of patients in medical research

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    FDA expanding COVID vaccine warnings over rare heart side effect

    FDA expanding COVID vaccine warnings over rare heart side effect

    June 27, 2025
    Supreme Court upholds HHS authority over ObamaCare preventative care task force

    Supreme Court upholds HHS authority over ObamaCare preventative care task force

    June 27, 2025
    Unusual pushback, ‘dangerous precedent’: What the first meeting of Kennedy’s CDC advisers reveals about the future of vaccines in America

    Unusual pushback, ‘dangerous precedent’: What the first meeting of Kennedy’s CDC advisers reveals about the future of vaccines in America

    June 27, 2025

    Trending

    Americans with poor diet fall from 49 percent to 37 percent: Study

    Americans with poor diet fall from 49 percent to 37 percent: Study

    June 18, 2024
    Examining new weight-loss drugs, pediatric bariatric patients

    Examining new weight-loss drugs, pediatric bariatric patients

    August 30, 2024
    HHS removes surgeon general’s gun violence advisory from its website

    HHS removes surgeon general’s gun violence advisory from its website

    March 20, 2025
    Some measles patients in West Texas show signs of vitamin A toxicity, doctors say, raising concerns about misinformation

    Some measles patients in West Texas show signs of vitamin A toxicity, doctors say, raising concerns about misinformation

    March 28, 2025

    Recent News

    FDA expanding COVID vaccine warnings over rare heart side effect

    FDA expanding COVID vaccine warnings over rare heart side effect

    June 27, 2025
    Supreme Court upholds HHS authority over ObamaCare preventative care task force

    Supreme Court upholds HHS authority over ObamaCare preventative care task force

    June 27, 2025

    Popular News

    • FDA expanding COVID vaccine warnings over rare heart side effect
    • Supreme Court upholds HHS authority over ObamaCare preventative care task force

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.